Turn Therapeutics (TTRX) Operating Expenses (2024 - 2026)

Turn Therapeutics' Operating Expenses history runs 3 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 223.68% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.9 million, up 226.0% from the prior year.
• Operating Expenses slipped to $1.2 million in Q1 2026 per TTRX's latest filing, from $2.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $2.2 million in Q4 2025 and bottomed at $328957.0 in Q4 2024.
• The 3-year median for Operating Expenses is $959567.5 (2024), against an average of $1.1 million.
• Biggest YoY gain for Operating Expenses was 566.83% in 2025; the steepest drop was 184.34% in 2025.
• Year by year, Operating Expenses stood at $328957.0 in 2024, then soared by 566.83% to $2.2 million in 2025, then tumbled by 43.19% to $1.2 million in 2026.
• Per Business Quant, the three latest TTRX Operating Expenses figures stand at $1.2 million (Q1 2026), $2.2 million (Q4 2025), and $1.9 million (Q3 2025).